Just-approved flu vaccine uses newer production method

November 21, 2012
Just-approved flu vaccine uses newer production method

(HealthDay)—Flucelvax is the first seasonal flu vaccine to be approved by the U.S. Food and Drug Administration using a manufacturing method called cell culture technology, the agency said.

Other flu vaccines are produced inside eggs. But that process takes longer than the newer method and could be harmful to people with egg allergies, the FDA explained. In cell culture technology, are grown inside mammalian .

This technology has been used for decades to produce other vaccines, the agency said, and since it is quicker, it can be used more efficiently to develop flu vaccines rapidly in the event of a pandemic.

Flucelvax was evaluated in clinical studies in the United States and Europe involving some 7,700 people ages 18 to 49. Common side effects included pain, redness, injection-site soreness, headache, and fatigue—reactions typically seen in people given egg-based flu vaccines, the FDA said.

The U.S. Centers for Disease Control and Prevention recommends the annual for anyone 6 months and older.

Flucelvax is produced by Novartis Vaccines and Diagnostics, based in Marburg, Germany.

Explore further: FDA approves flu vaccine for coming season

More information: More Information

Related Stories

FDA approves flu vaccine for coming season

August 14, 2012

(HealthDay) -- The formulation for the vaccine that will help protect against the flu this coming season was approved by the U.S. Food and Drug Administration on Monday.

New development could increase flu vaccine supply

June 2, 2011

(Medical Xpress) -- Scientists from the U.S. Food and Drug Administration and the pharmaceutical company Novartis announced today in the journal Science Translational Medicine that they have developed a new adjuvant, or compound ...

Germany orders recall of some Novartis flu shots

October 25, 2012

(AP)—German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.